Keratoconus : Causes, symptoms & treatment options in Turkey

What is keratoconus and who does it affect?

Keratoconus derives its name from Greek: literally, a cone-shaped cornea. In this progressive, non-inflammatory disorder, the cornea, normally smooth and dome-like, gradually loses thickness and protrudes forward into an irregular conical form. Light entering the eye scatters rather than focusing cleanly onto the retina, resulting in progressively blurred and distorted vision that worsens over time.

Onset typically occurs during the teenage years. The condition continues to evolve through the 30s and into the 40s, after which it frequently stabilizes. Almost always bilateral, though one eye may show more pronounced changes than the other.

A 2021 systematic review in Ophthalmology (the official journal of the American Academy of Ophthalmology) found global keratoconus prevalence at roughly 1.38 per 1,000 individuals. Higher concentrations appear in the Middle East, South Asia, and North Africa. This geographic distribution explains why international patients from these regions increasingly pursue keratoconus treatment in Turkey, where advanced eye centers now attract patients from across three continents seeking both expertise and cost-effective care.

What are the symptoms of keratoconus and when should you see a doctor?

Early detection is notoriously challenging. The initial signs often mirror ordinary refractive errors. Watch for these:

• Vision that blurs or distorts unpredictably; spectacle prescriptions requiring updates every few months or even sooner.
• Monocular diplopia, 'ghost images' visible to one eye alone, persisting even behind glasses.
• Heightened light sensitivity (photophobia) and glare, most bothersome after sunset.
• Halos surrounding streetlights and difficulty with nighttime driving; this affects quality of life significantly.
• Compulsive eye rubbing. Often linked to allergies or dryness, this habit itself weakens the cornea.
• Unexplained eye irritation.

The crucial warning sign? Rapidly changing vision. If your prescription shifts every 6–12 months and standard glasses no longer adequately correct your sight, ask your ophthalmologist for a corneal topography scan. This detailed surface map is the gold standard for diagnosis. Early identification fundamentally reshapes your treatment options and prognosis.

What are the stages of keratoconus?

The Amsler-Krumeich classification system remains the globally accepted standard for staging keratoconus severity. Your assigned stage directly shapes treatment strategy:

Critical point: Early-stage disease responds best to intervention. If you fall between stages 1 and 2 and progression continues, cross-linking offers the most compelling evidence for halting advancement before reaching advanced stages where corrective options narrow considerably.

What causes keratoconus?

Medical research consistently identifies multiple suspicious factors. Yet no single cause fully explains every case.

Genetic predisposition

Family clustering appears repeatedly in clinical records. Many patients report a relative, parent, sibling, or cousin, with the same diagnosis. This familial pattern strongly suggests hereditary transmission, though researchers have yet to isolate a single responsible gene. The genetic component is now virtually undisputed.

If a first-degree relative carries this diagnosis, periodic eye exams become prudent, particularly for young family members and adolescents entering the typical age of onset.

Environmental aggravating factors

Heredity alone does not determine destiny. External triggers can accelerate or amplify the process. Three emerge repeatedly:

• Vigorous eye rubbing, frequently tied to allergies or chronic dryness. This mechanical stress directly compromises corneal architecture.
• Long-term or improper contact lens wear, particularly rigid designs. In susceptible individuals, this accelerates deformation.
• Chronic unprotected UV exposure.

These everyday habits, when repeated, inflict measurable damage on corneal biomechanics.

Hormonal involvement?

Since onset clusters around puberty and early adulthood, hormonal shifts may prime the cornea for weakness. Structural changes in collagen and proteoglycans during these transitions could explain the temporal pattern.

Systemic disease associations

Certain genetic syndromes carry elevated keratoconus risk:

• Down syndrome (trisomy 21).
• Marfan syndrome, characterized by connective tissue fragility.
• Osteogenesis imperfecta, which weakens skeletal collagen.

These associations point toward underlying collagen or connective tissue defects as contributing mechanisms.

What are the keratoconus treatment options available in Turkey?

Effective management pursues two parallel goals:

1. Halt or slow corneal deterioration before irreversible damage occurs.
2. Optimize vision within the constraints of current corneal shape.

Treatment selection depends entirely on disease stage and progression velocity.

Corneal cross-linking: The disease-stopping foundation

Cross-linking stands alone as the only intervention with solid, replicated evidence for halting keratoconus progression. The mechanism is straightforward: riboflavin (vitamin B2) solution is instilled into the corneal stroma, then activated with controlled UVA illumination. This photochemical reaction creates new covalent bonds between collagen fibrils, dramatically stiffening the tissue and resisting further cone formation.

A 2023 Cochrane review (the gold standard in systematic evidence) documented that accelerated CXL arrests progression in over 90% of treated eyes at 3-year follow-up. It does not erase pre-existing deformation, but it freezes the process, precisely what early-to-moderate disease requires. Concretely, this means most patients avoid more invasive surgery.

The partner clinics of Turquie Santé perform cross-linking under topical anesthesia (eye drops only),requiring 60–90 minutes total and no overnight hospitalization. Temporary light sensitivity and mild discomfort typically resolve within 48–72 hours. Functional vision normalizes within 1–2 weeks in the majority of cases.

Intracorneal ring segments: Non-transplant reshaping

When spectacles and contact lenses fail to provide adequate vision and disease activity has plateaued, intracorneal ring segments offer surgical reshaping. Small synthetic arcs are inserted into the corneal stroma to flatten and regularize surface curvature, producing both structural improvement and better optical alignment. Two key advantages: reversibility and preservation of the patient's own corneal tissue.

ICRS frequently combines with CXL in a single session. The procedure relies on precise topographic mapping to determine segment size and position. Turkish corneal centers increasingly adopt this combined approach for moderate cases, with excellent refractive outcomes reported at the 6-month mark.

Topography-guided excimer laser (PRK / Trans-PRK)

After cross-linking stabilizes the cornea, laser surface ablation based on detailed topography maps can further regularize the shape and address residual myopia or astigmatism. This is adjunctive, not primary, applied once the disease has been arrested and the cornea proven stable on serial imaging.

Corneal transplantation: When conservative options exhaust

Reserved for advanced cases (Stage 3-4) where irregular scarring or extreme thinning defeats all optical approaches. Two distinct surgical strategies exist:

• DALK (Deep Anterior Lamellar Keratoplasty): Replaces only the damaged anterior layers while preserving the patient's own inner cornea. This reduces rejection risk and is preferred when the back layers remain healthy.
• PKP (Penetrating Keratoplasty): Full-thickness replacement. Reserved for severe cases with deep central scarring.

Clinical note: A 2022 meta-analysis in Ophthalmology demonstrated DALK carries significantly lower endothelial rejection rates than PKP (2.4% versus 7.6% at 5 years),with equivalent long-term visual results. Most clinics at Turquie Santé partner networks now favor DALK where anatomically feasible.